Novartis AG
Article Abstract:
A comparative analysis of the company sales and earnings and the financial details of Novartis AG from 1997 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Sales, profits & dividends, Switzerland, Company sales and earnings, Company earnings/profit
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Novartis AG
Article Abstract:
The price appreciation potential of the shares of Novartis AG for the years 2010-2012 is discussed. The Basel, Switzerland-based firm is a major pharmaceutical and health care company.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
United States, Evaluation, Stocks, Stock prices, Analyst report
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Pharmaceutical industry, Switzerland, Novartis AG, Securities, Company securities, NVTSY
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.